脱细胞神经同种异体移植角膜神经化的多中心病例系列结局
该回顾性多中心病例系列纳入17例因感染、三叉神经麻痹或眼外伤导致角膜麻醉的患者,采用人尸体脱细胞神经同种异体移植行角膜神经化。术后角膜感觉从术前平均0.36 cm提高至4.42 cm(p<0.01),首次和最大感觉恢复分别平均在3.7个月和6.6个月,无并发症,视力无变化。
要点
- 脱细胞神经同种异体移植角膜神经化安全有效,无术中或术后并发症。
- 角膜感觉从术前平均0.36 cm提高至术后4.42 cm(p<0.01)。
- 端端与端侧吻合、供神经选择或供眼侧别间结局无统计学差异。
核心结论
- 使用脱细胞神经同种异体移植行角膜神经化是安全有效的手术。
- 本研究为脱细胞神经同种异体移植用于角膜神经化提供了进一步证据。
研究设计与样本
- 回顾性病例系列,纳入17例接受人尸体脱细胞神经同种异体移植角膜神经化的患者。
- 所有患者均有术前和术后最佳矫正视力描述及角膜感觉测量。
- 按手术技术分层后进行对比分析。
主要发现
- 角膜麻醉原因:既往感染8例,三叉神经麻痹8例,眼外伤1例。
- 无术中或术后并发症。
- 首次获得角膜感觉和最大感觉增益分别平均在3.7个月(范围1-8个月)和6.6个月(范围3-15个月)。
- Cochet-Bonnet角膜感觉计测量术前平均0.36 cm(范围0-3.2 cm),术后平均4.42 cm(范围0-6 cm),p<0.01。
- 神经化后视力无变化;端端与端侧吻合、供神经选择或供眼侧别间结局无统计学差异。
临床怎么用
- 对于角膜麻醉患者,可考虑采用脱细胞神经同种异体移植行角膜神经化以恢复角膜感觉。
- 术后角膜感觉恢复需数月,首次感觉增益平均约3.7个月,最大增益平均约6.6个月。
局限性
- 回顾性病例系列,样本量17例。
- 原文未报告随访时长、供体神经具体类型及手术技术细节的量化数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Corneal neurotisation is a rapidly evolving procedure treating neurotrophic keratopathy. The variety of surgical techniques used and corresponding outcomes after corneal neurotisation are not well understood. This study describes the techniques and outcomes in the largest case series of corneal neurotisation using processed nerve allografts to date. METHODS: This is a retrospective case series of patients who underwent corneal neurotisation with human cadaveric processed nerve allografts. All patients had preoperative and postoperative description of best corrected visual acuity and measurement of corneal sensation. Comparative studies after stratification of techniques were performed. RESULTS: A total of 17 patients were identified. The cause of corneal anaesthesia was prior infection in eight cases, trigeminal nerve palsy in eight cases and ocular trauma in one case. There were no intraoperative or postoperative complications. Following neurotisation surgery, the time to first gain of corneal sensation and maximal gain of sensation occurred at a mean of 3.7 months (range 1-8 months) and 6.6 months (range 3-15 months), respectively. The mean preoperative and postoperative corneal sensation as measured by Cochet-Bonnet aesthesiometry was 0.36 cm (range 0-3.2 cm) and 4.42 cm (range 0-6 cm), respectively (p<0.01). Visual acuity was unchanged after neurotisation. There were no statistical differences in outcomes based on end-to-end versus end-to-side coaptations, donor nerve selection or laterality of donor nerve. CONCLUSION: Corneal neurotisation with processed nerve allografts is a safe and effective procedure. This study provides further evidence for the use of processed nerve allografts for corneal neurotisation.
引用
- Sweeney AR, Wang M, Weller CL, et al. Outcomes of corneal neurotisation using processed nerve allografts: a multicentre case series. Br J Ophthalmol. 2020. PMID: 33199302. doi:10.1136/bjophthalmol-2020-317361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。